Next: Get access to a new market-moving chart every day featuring a stock ... success criterion for non-inferiority to comparator antiretroviral therapies and primary safety objectives at Week ...

A blood test to detect antiretroviral drugs showed that only 4% of those with viremia ... recruited 569 men living with HIV who had been traced from chart reviews at 13 health facilities. Men were ...

Additionally, no drug-resistance mutations were observed at the end of the study. Long-acting formulations of VH184 in adults without HIV are being evaluated in an ongoing phase 1 study.

The impact of economic growth is shown in Chart 2 by the “growth” arrow that ... In the areas of sub-Saharan Africa most affected by the HIV/AIDS pandemic, broader access to antiretroviral drugs and ...

North America was the major shareholder in 2022. However, Asia-Pacific is expected to witness the highest CAGR during the forecast period. PO ...

Dolutegravir plus lamivudine shows comparable efficacy and safety with standard-of-care three-drug regimen in patients with ...

More than 40 drugs are now available to treat HIV infection Medically reviewed by Lindsay Cook, PharmD Fact checked by Sarah Scott Antiretroviral drugs are used to treat HIV infection. They work ...

In the second trial, which was open label, 95.6% of participants who switched to DOR/ISL maintained viral suppression ...

Data from two studies suggest that a once-daily combination therapy of doravirine and islatravir was noninferior to current, ...